Perceptions of hypertension treatment among patients with and without diabetes by Anthony, Heymann et al.
RESEARCH ARTICLE Open Access
Perceptions of hypertension treatment among





1,2 and Shalev Varda
1,2
Abstract
Background: Despite the availability of a wide selection of effective antihypertensive treatments and the existence
of clear treatment guidelines, many patients with hypertension do not have controlled blood pressure. We
conducted a qualitative study to explore beliefs and perceptions regarding hypertension and gain an
understanding of barriers to treatment among patients with and without diabetes.
Methods: Ten focus groups were held for patients with hypertension in three age ranges, with and without
diabetes. The topic guides for the groups were: What will determine your future health status? What do you
understand by “raised blood pressure”? How should one go about treating raised blood pressure?
Results: People with hypertension tend to see hypertension not as a disease but as a risk factor for myocardial
infarction or stroke. They do not view it as a continuous, degenerative process of damage to the vascular system,
but rather as a binary risk process, within which you can either be a winner (not become ill) or a loser. This makes
non-adherence to treatment a gamble with a potential positive outcome. Patients with diabetes are more likely to
accept hypertension as a chronic illness with minor impact on their routine, and less important than their diabetes.
Most participants overestimated the effect of stress as a causative factor believing that a reduction in levels of
stress is the most important treatment modality. Many believe they “know their bodies” and are able to control
their blood pressure. Patients without diabetes were most likely to adopt a treatment which is a compromise
between their physician’s suggestions and their own understanding of hypertension.
Conclusion: Patient denial and non-adherence to hypertension treatment is a prevalent phenomenon reflecting a
conscious choice made by the patient, based on his knowledge and perceptions regarding the medical condition
and its treatment. There is a need to change perception of hypertension from a gamble to a disease process.
Changing the message from the existing one of “silent killer” to one that depicts hypertension as a manageable
disease process may have the potential to significantly increase adherence rates.
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Background
Hypertension is a leading cause of cardiovascular mor-
bidity and mortality. In 2006 in the Unites States, hyper-
tension was documented as the primary cause of death in
over 56,000 deaths and as a contributing factor in an
additional 250,000 deaths out of the 2.4 million deaths
reported for that year [1]. Hypertension is a common
chronic disease, estimated to affect over 29% of the adult
population as reported in The National Health and
Nutrition Examination Survey (NHANES) 1988-1994
and 1999-2008, which represents a probability sample of
the US civilian population [2]. The high prevalence of
hypertension together with its deleterious effect on health
make it a major public health problem; In a recent report
the Institute of Medicine called hypertension “a neglected
disease that is often ignored by the general public and
underappreciated by the medical community” [3]. Despite
the availability of a broad selection of effective antihyper-
tensive treatments and the existence of clear treatment
guidelines, approximately one third of hypertensive
patients do not have their blood pressure controlled.
Hypertension is a particularly important issue among
people with diabetes as it is a significant contributor to
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nopathy as well as increasing cardiovascular mortality [4].
In a study conducted between September 2005 and
March 2006 in 26 countries, overall blood pressure (BP)
control rate was 33.6% in men and 30.6% in women (P <
0.0001) and was lower in diabetic as compared with non-
diabetic patients [5]. Factors affecting BP control can be
identified at the level of the patient, the health provider
and the health system [6]. One of the major problems
identified in the literature is poor adherence to medication
among patients, which has been reported to range
between 43% to 88% [7]. If optimal blood pressure treat-
ment is seen as a combination of medications and lifestyle
modifications, the level of adherence to recommendations
is even lower [8]. Hypertension treatment often requires a
combination of medications. Patients may choose to take
all or some of the prescribed medications resulting in
varying levels of non-adherence [9].
A recent study of 4783 patients who participated in
studies whose dosing histories were available through
electronic monitoring showed that among patients pre-
scribed once a day antihypertensive drugs, non-persis-
tence is the major problem: half of the patients stopped
treatment within a year and 48% admitted to at least one
“drug holiday” (not adhering to medications for a short
period of time) a year [10]. Patient adherence to pre-
scribed treatment is a complex phenomenon, known to
be influenced by patient knowledge and beliefs about his
disease and about the benefits and risks of its treatments
[11]. Many reasons have been cited which may prevent
physicians from treating hypertension effectively. Among
those cited is failure to adhere to treatment guidelines,
problems in physician-patient communication, a lack of
training and skills in lifestyle counseling and work under
severe time constraints [6,12]. The difficulty of accepting
and coping with a diagnosis of hypertension has been
described in a number of studies. In one study as many
as 66% of patients had difficulty accepting the diagnosis
of hypertension [13]. Patient denial, mistrust and hope-
lessness regarding hypertension have been reported in a
small qualitative study [14]. Patients with diabetes usually
adhere to medication regimes for the treatment of hyper-
t e n s i o na n da r em o r el i k e l yt oa d h e r et ot h e s et h a nd i e t -
ary and lifestyle modifications, but are more willing to do
so if their physician advises them to [15,16]. This has
become even more important in view of the positive
effects of the DASH diet in relation to disease progress in
diabetes as well as hypertension [17].
Possible problems at the health system level include
insufficient availability of medical services, cost of medica-
tions and poor patient adherence. The focus of this study
is on the reasons that patients do not adhere, or adhere
only partially to medication and lifestyle regimes.
In spite of the fact that hypertension is easy to identify,
and that there are a variety of pharmaceutical and non-
pharmaceutical (such as salt reduction, dietary modifica-
tion and weight loss) evidence-based treatment options
available, we are failing miserably at hypertension control.
If we can gain an understanding of why people with hyper-
tension who have been advised what they need to do and
provided with prescriptions for inexpensive and readily
available medications are not adhering to treatment, we
will be able to modify the ways in which we communicate
with patients in order to increase adherence. The aim of
this study was to gain a deeper understanding of the
beliefs, attitudes and coping mechanisms of patients with
hypertension. We also aimed to examine the differences
between males and females, and between younger and
older age groups, and the differences between those who
had an additional, more severe chronic disease; diabetes,
and those who do not, in regards to hypertension and its
treatment. Focus group methodology was chosen in order
to generate hypotheses for further research. Better under-
standing of these perceptions can help both the physicians
and the health system to develop effective communication




This qualitative study was conducted in a large publicly
financed health maintenance organization with 1.9 million
members. Membership is open to all sectors in the general
population. A computerized medical record is used and
complete clinical data have been collected in a central
database since 1995. Based on these data, diabetes and
hypertension registries have been developed. These are
built using algorithms that identify members who have the
disease, and are continually validated by physicians. There
are over 250,000 people in the hypertension registry, of
which approximately 60,000 are also in the diabetes regis-
try. This study was approved by our institutional review
board. Informed consent was not required.
Population selection
Participants in the patient focus-groups were randomly
selected from the hypertension registry. Randomization
was stratified by age, gender and diabetes status, as these
factors were expected to influence patient’sa t t i t u d e s
regarding hypertension and their mode of management.
We produced a list of 150 potential participants, and
patients were contacted by phone and asked to participate
in focus groups on a health issue. Patients were contacted
until the required number was recruited. We did not ask
the reasons for non participation. Participants were not
aware of the topic of the focus group. They were invited
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were compensated for their time. This was designed to
achieve diverse opinions organized by age and gender. The
study design was based on several assumptions: That men
and women would discuss health issues more freely in
separate groups, that attitudes towards hypertension
would differ between younger and older patients, and that
those who have an additional chronic disease, which is
perceived as more severe, may have different attitudes
towards chronic disease in general, and hypertension in
particular. We therefore conducted separate focus groups
were for men and women with hypertension in three age
ranges: 41-50, 51-60, 61-70 years (a total of six groups),
and for men and women with hypertension and diabetes
in two age ranges: 51-60, 61-70 years (a total of four
groups). A lower cutoff age of 40 was selected as the
majority of patients in the hypertension registry are aged
40 and over, and we felt that we should address the issue
in a relatively homogenous group, as it may be that treat-
ing a much younger hypertensive is a totally different
issue.
Focus-group preparation
Topic guides for the patient groups were developed by a
multidisciplinary team which consisted of a health promo-
tion expert, primary care physicians, nurses and social psy-
chologists. The topic guide for the patient’s focus group
covered the following domains:
1) What will determine your future health status
(Probe: current health situation, lifestyle, luck, and
genetics).
2) What do you understand by “raised blood pressure”
(Probe: causes, risks, treatments, personal and family
experiences, impact on function).
3 )H o ws h o u l do n eg oa b o u tt r e a t i n gr a i s e db l o o d
pressure? (Probe: difficulties, side effects of treatments
including impact on sexual function, coping mechan-
isms, attitudes of primary care medical team).
Focus-group sessions
These were facilitated by one of two psychologists. The
male psychologist ran the male groups and the female
psychologist the other groups. Each session included 7-
10 participants and lasted 1.5-2 hours. Sessions began
with brief introductions followed by a short discussion
on health in general, and how participants view their
own health. Hypertension was introduced as the subject
of the study using open questions included in the topic
guide. New topics were introduced after everyone
wishing to express their opinions had finished doing so.
Having obtained consent discussions were audio taped
and transcribed verbatim, in addition to documentation
of the discussion by the psychologists during the sessions.
The venue selected for the sessions was not identified
with any health organization. Participants were not
informed at any point who is conducting the study, what
the aim of the study is, or how participants were selected.
Data analysis
The same or following day the written notes were typed
and compared with the audiotape. An overview grid was
constructed which provided a descriptive summary with
topic headings on one axis and focus group identifiers on
the other [18]. The strength of consensus for each topic
was assessed. The break characteristics used to differenti-
ate subsets of the target population were age, patients
who also had diabetes and patient gender. The material
collected in the focus groups was analyzed for recurrent
themes separately by several experts, and cross refer-
enced to identify incidents of misidentification. Central
categories were identified within the material, and docu-
mented according to the pre-identified research ques-
tions. Deviant cases were discussed. The summaries were
then reviewed again, to verify, adjust and re-allocate cate-
gories. Lastly, the relationship between the categories and
the dynamics between them were presented as power
fields within which the research issue is examined [19].
The number of groups selected reflects the minimal
number that is necessary to represent the relevant popu-
lations. The number of groups and population distribu-
tion within each group were determined by the minimal
number required to obtain an appropriate picture of the
research issues as presented in the research questions.
The number of groups necessary was determined by the
variety and the size of each of the sub-populations in the
hypertension registry. In this way we determined that our
samples were of sufficient size, number and variety to
ensure a reasonable level of information saturation.
Results
We conducted ten focus groups, with 86 patients: 42 men
and 44 women Of these, 37 participants had both hyper-
tension and diabetes. Most of the participants initially
denied having “hypertension”, and when coaxed, all agreed
that they had a “blood pressure problem” or that occasion-
ally their blood pressure was higher than normal. The first
issue that was brought up was the issue of health in gen-
eral, and future health in particular. The word/phrase
codes that were dominant regarding the question of future
health status were “stress” and “lifestyle”. Participants did
not, in general, bring up the issue of chronic illness in gen-
eral, or diabetes in particular. The issue of hypertension
was not mentioned by any participant. Regarding the
question of “What do you understand by raised blood
pressure?” t h eh i g h e s tr a n k i n gc o d eb yf a rw a s“stress”.
Codes relating to chance/fate were also dominant in this
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“stroke heart attack”. The dominant codes that were
recorded regarding the treatment question were “medica-
tions”, “stress”. Side effects came low in the ranking. The
focus groups were divided according to gender because
our assumption was that the medications’ effect on sexual
function would be an important theme. This turned out
not to be the case.
Patients’ perception of hypertension
Patients with diabetes regard hypertension as just
another health problem: “It is a disease like any other
disease and it has treatment... pills and diet”
All patient groups expressed the view that hypertension
is less of a disease and more of a risk factor because of its
potential for dramatic events: “It is a silent disease called
‘the silent killer’... it is very dangerous mainly since you do
n o tf e e li ta n di tc a u s e ss e v e r ed a m a g e . . .i tk i l l s ”. “With
hypertension you feel healthy... there are no ill effects... you
take a pill and you can forget. In diabetes it is a different
story. It’s a different feeling and demands my full atten-
tion... you can’tf o r g e ti t . ”
Most patients in both groups avoid calling hypertension
a disease, because of its asymptomatic nature. “It is a lim-
itation but not a disease because you feel healthy”
However patients with diabetes who already have a
chronic disease label, are willing to accept that hyperten-
sion is a chronic condition. Patients without diabetes gen-
erally found it difficult to accept that hypertension is a
chronic condition and see it as a physiological reaction to
stress.
“I see it as a problem and not a disease... “
“Blood pressure is a control light of the body.... When it
is high it is a sign that something is wrong and you need
to treat it”
A recurrent theme in the discussions was that the
patients attribute personal stress as a significant cause of
their elevated blood pressure and as a result they view
stress reduction as an effective way to control it.
“I learned not to get angry and not have my feelings
hurt but when I get angry even about something small I
feel how my blood pressure rises”
The discussions exposed gaps in the patient understand-
ing of the hypertension, its possible consequences and the
factors affecting it. This was clearly expressed by the dia-
betic patients who reported that the explanation they
received regarding diabetes was much more comprehen-
sive than the explanation received regarding hypertension.
Both groups felt that hypertension does not cause immedi-
ate damage, and is in fact similar to a time bomb, which
can either explode or not. Diabetic patients specifically sta-
ted that while diabetes is an insidious disease that causes
immediate damage, hypertension is more like a risk factor
for future events.
Patient modes of management
Patients presented a few modes of coping with hyper-
tension, depending on their individualized perceptions
regarding the disease and its treatments:
Full adherence
A minority of the participants followed a combination of
adherence to medications and “drastic” lifestyle
modifications
Compromise
This mode reflects a compromise between the ‘ideal
treatment’ and ‘palatable’ treatment which is reached by
balancing the perceived importance of the treatment
and the degree of disruption to their desired lifestyle
that this treatment involves. These patients found it
easier to comply with taking pills than to change their
diet, quit smoking or exercise.
“... so I take pills, sometimes eat healthy, swim a little...
I am not willing to invest everything in health, hyperten-
sion will not disrupt my lifestyle”. It seems that even the
random occurrences of forgetting to take a pill or to
renew the prescription on time comes from a decision
to not to put too much thought and effort into the
treatment.
Self-adjustment: These patients modulate their doc-
tor’s orders. They believe they “know their bodies” and
hence have a better ability to better control their blood
pressure. They tend to overestimate the effect stress car-
ries on blood pressure: “I learned to control stress and
according to that I lower the dosage of my pills or
increase it”. Out of the treatment modalities, they tend
to prefer lifestyle modifications over medications which
they often perceive as a mechanistic and impersonal
approach.
No treatment: There are patients who not treat their
blood pressure, either because they deny having elevated
blood pressure or they deny the need to treat it. By
denying the disease they avoid facing the anxiety that is
associated with the diagnosis.
“If there is high blood pressure, I do not want to
know... thinking of that makes me anxious... I am healthy
because I feel healthy”
There are patients who stopped taking anti-hyperten-
sive medication because they view hypertension as a
temporary state and not as a lifetime diagnosis. Some
stopped their treatment because they had an adverse
reaction and for them that was the only negative mani-
festation of their blood pressure: “The doctor found that
I have blood pressure. The pill caused heartburn so I
stopped taking it.”
Patients who also had diabetes described two different
coping strategies for dealing with their hypertension.
Some saw hypertension as a separate and less important
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mise group": “Hypertension is a small issue for me. I
take pills because they are part of my life today but no
more than that. Most of my energy is invested in dia-
betes.” Others dealt with both conditions using a holistic
“Full adherence” approach: “ T h ed i a b e t e sf o r c e sm e . . .i t
screams at me and in order to deal with it I need to be
strict. So there is no separation of hypertension from dia-
betes... you live a more healthy life”. Another patient sta-
ted: “ If you want to live a long life you need to be
active, live a strictly healthy lifestyle and deal with all
disease. So that diabetes, cholesterol and hypertension
are all in the same basket.”
Table 1 summarizes the main differences between
those hypertensive patients with and without diabetes.
Discussion
Listening to patients as “experts” is essential in addressing
barriers to adherence with medical advice [20]. In this
study we explored some of the attitudes and perceptions
held by hypertensive patients with and without diabetes,
regarding hypertension and its management. When com-
paring between the two groups, we found several differ-
ences. Patients with diabetes are more accepting of the
fact that hypertension is a chronic condition that needs to
be treated systematically for the duration. This may be
related to their having accepted their role as a patient with
a chronic illness in relation to diabetes, and also to their
being, as a rule, older than participants without diabetes,
and therefore more open to the deterioration of health
associated with ageing. Patients with diabetes saw hyper-
tension treatment as non-burdensome in comparison with
the rigors of caring for their diabetes. There was one
major issue, however, which was common to all partici-
pants: the view that hypertension is a gamble, which can
either have or not have serious effects in the future. The
well-established positioning of hypertension as the ‘silent
killer’ may have captured the public imagination but it
also may have a distinct downside: it downplays the
chronic damage caused by hypertension. This was clearly
expressed in the focus group discussions by one diabetic
patient who visualized hypertension as a snake that can
quietly and suddenly strike you and diabetes as a worm
that eats you slowly. As a result, patients view non-adher-
ence with treatment as a type of gamble which may be
successful so long as no catastrophe happens. This finding
adds an explanatory layer to findings from a recent quali-
tative study that found that patients see hypertension as a
serious disease but do not adhere to treatment [21]. We
can only speculate that if patients were better informed
about the chronic damage inevitably caused by exposure
to elevated blood pressure, then they would be more
inclined to adhere to their advised treatment, since fear of
complications was shown to be a solid reason for treat-
ment adherence [22].
The focus group discussions showed that in general
most patients are aware of the recommendations to
combine medical treatment with lifestyle modification.
However, only a minority of them adhered to these
recommendations. More commonly, patients choose to
combine only some of the recommended treatment ele-
ments (e.g. pharmacotherapy, dietary salt reduction etc.)
and only to a certain extent. Patients’ selection of a
mode of management is influenced on the one hand by
their perceptions regarding the dangers of hypertension
and the necessity of treatment and by their personal
experiences and beliefs about the various treatment
modalities. The lay perception of stress as a dominant
cause of hypertension can be found in many cultures
and supports the tendency of these patients to abandon
their pharmacotherapy and adopt less established treat-
ment modalities such as meditation [21,22], or, as we
found, to take their medications only when they are feel-
ing stressed.
At the other end of the spectrum there are patients
who focus on adhering to medications, and view it as a
sufficiently appropriate substitute to the more demand-
ing and time consuming recommended lifestyle changes.
Table 1 Summary of focus group findings
Issue Hypertensive patients with diabetes Hypertensive patients without diabetes
Hypertension as a
disease




Hypertension has the potential to cause major damage but minor in
comparison with diabetes
Hypertension has the potential to cause major damage
Impact of disease As opposed to diabetes, which cause cumulative damage
hypertension does no immediate damage and is a long term risk
factor for an outcome that may or may not happen
Hypertension does no immediate damage and is a long




Treatment is easy compared to care of diabetes and becomes part of
their routine





Effect is acknowledged but thought to be minor compared with
diabetes
None of the male participants acknowledged any
impact
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regarding hypertension treatment, and particularly in
relation to lifestyle changes is essential [23,24].
A possible strategy to improve hypertension manage-
ment is public education both for the general population
and people with hypertension [25]. Insights obtained
from these focus groups specifically regarding miscon-
ceptions about potential damage from hypertension
should be further investigated and used to formulate
future educational messages.
Strengths and limitations: Focus group study design is
used to generate a hypothesis. These focus groups enabled
us to gain a deeper understanding of patients’ perceptions
of the term “hypertension” and of possible sources of mis-
communication in the clinical setting, due to the open dis-
cussions that occurred in the groups. Holding separate
focus groups for patients of different ages and genders can
expose a wide range of views that are not usually
expressed in the routine patient-doctor encounter. One of
the major limitations of the study is that participants in
the focus groups do not form a representative sample of
the population. Our research design did not allow us to
identify ethnic or socioeconomic differences between
those who agreed to participate in the focus groups and
those that declined. More importantly the mere participa-
tion in focus groups select a population with higher health
awareness so it is expected that the group discussions gave
an underestimated picture of patients’ non adherence. It
may be that the authors (ADH and LV) who were present
during the discussions which formulated the topic guides
may have unduly influenced their formulation.
Conclusion
This study suggests that patients as a rule do not see
hypertension as a chronic disease requiring adherence to
treatment recommendations, but rather as a health condi-
tion mainly related to stress, that may actually have no
consequences if left untreated. Although we found little
difference between age and gender groups, patients with
diabetes have a different view of hypertension than those
who do not. Patient denial and non-adherence with hyper-
tension treatment seems to be a prevalent phenomenon
reflecting a conscious active choice made by the patient,
based on his knowledge and perceptions regarding the
medical condition and its treatment. Specifically referring
to hypertension as an illness, highlighting the chronic
damage caused by exposure to high values of blood pres-
sure and providing patients with information about the
importance of the various treatment modalities in a way
that would address their individual reservations may
improve control of both diabetes and hypertension.
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